Form 13-F position report

INTEGRA LIFESCIENCES HLDGS

Reported by BNP Paribas Asset Management Holding S A

IART 0.5 08/15/25 CUSIP 457985AM1 Manager CIK 0001520354

Reported 4,500,000 shares, unchanged from the prior quarter.

Reported value -5.9%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 0.01% This manager · Q2 2023
Shares 4,500,000 Quarter-end amount reported
Reported value $4,103,000 Fair value at quarter end
Consecutive quarters held 10 Through Q2 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 4918000
2022-03-31 4721000
2022-06-30 4260000
2022-09-30 3935000
2022-12-31 4370000
2023-03-31 4361000
2023-06-30 4103000
2023-09-30 4110000
2023-12-31 4226000
2024-03-31 4311000
2024-06-30 2831000
2024-09-30 2851000
2024-12-31 2886000
2025-03-31 2947000
2025-06-30 2975000
2025-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for INTEGRA LIFESCIENCES HLDGS held by BNP Paribas Asset Management Holding S A.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2025 Reduced 0 -3,000,000 (-100.0%) 0 $0 2025-11-07
Q2 2025 Unchanged 3,000,000 0 (0.0%) < 0.01% $2,975,000 2025-08-06
Q1 2025 Unchanged 3,000,000 0 (0.0%) < 0.01% $2,947,000 2025-05-14
Q4 2024 Unchanged 3,000,000 0 (0.0%) < 0.01% $2,886,000 2025-02-12
Q3 2024 Unchanged 3,000,000 0 (0.0%) < 0.01% $2,851,000 2024-11-08
Q2 2024 Reduced 3,000,000 -1,500,000 (-33.3%) < 0.01% $2,831,000 2024-07-30
Q1 2024 Unchanged 4,500,000 0 (0.0%) 0.01% $4,311,000 2024-05-08
Q4 2023 Unchanged 4,500,000 0 (0.0%) 0.01% $4,226,000 2024-02-09
Q3 2023 Unchanged 4,500,000 0 (0.0%) 0.01% $4,110,000 2023-11-13
Q2 2023 Unchanged 4,500,000 0 (0.0%) 0.01% $4,103,000 2023-08-08
Q1 2023 Unchanged 4,500,000 0 (0.0%) 0.02% $4,361,000 2023-05-08
Q4 2022 Unchanged 4,500,000 0 (0.0%) 0.02% $4,370,000 2023-02-10
Q3 2022 Unchanged 4,500,000 0 (0.0%) 0.02% $3,935,000 2022-11-10
Q2 2022 Unchanged 4,500,000 0 (0.0%) 0.02% $4,260,000 2022-08-04
Q1 2022 Unchanged 4,500,000 0 (0.0%) 0.02% $4,721,000 2022-05-12
Q4 2021 Unchanged 4,500,000 0 (0.0%) 0.02% $4,918,000 2022-02-09
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

82 managers reported INTEGRA LIFESCIENCES HLDGS for Q2 2023.

Managers reporting INTEGRA LIFESCIENCES HLDGS in Q2 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Invesco Ltd Unchanged 58,000,000 0 0.01% $52,954,000 10 qtrs
HIGHBRIDGE CAPITAL MANAGEMENT LLC Added 54,248,000 +5,500,000 2.19% $49,653,737 9 qtrs
Linden Advisors LP New 32,000,000 +32,000,000 0.31% $29,278,335 1 qtr
Citigroup Inc Added 26,602,000 +1,975,000 0.02% $24,287,626 10 qtrs
MACKAY SHIELDS LLC Reduced 26,274,000 -221,000 0.67% $24,083,322 10 qtrs
Aequim Alternative Investments LP Reduced 25,000,000 -10,000,000 0.86% $22,950,000 8 qtrs
AVIVA PLC Unchanged 24,625,000 0 0.09% $22,453,518 9 qtrs
JPMorgan Chase & Co Reduced 23,134,000 -254,000 < 0.01% $21,174,781 10 qtrs
CAPSTONE INVESTMENT ADVISORS LLC Reduced 22,000,000 -5,000,000 0.1% $20,196,000 10 qtrs
DLD Asset Management LP Added 17,711,000 +1,535,000 1.77% $16,255,571 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2023
Filed
August 08, 2023
Filing type
13F-HR
Position type
NOTE 0.500% 8/1

Voting authority reported

Sole
0
Shared
61,083
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.